Many of the pharma owners from Dubai, Turkey and Europe expressed their instant interest to do joint collaboration with Bangladesh pharma industries
Dr Zareen Delawar Hussain, chief executive officer of Invicta Health Care in Bangladesh, participated in the 20th Middle East Pharma Congress held in Istanbul on November 11 and 12.
Around 70 delegates, pharma industry experts and researchers from around the world participated in this congress.
Dr Zareen, the most diversified and pioneer Health care professional, entrepreneur and philanthropist in Bangladesh, attended the conference as committee chair and keynote speaker.
Dr Zareen projected Bangladesh pharma industry as a most cost competitive potential hub for Contract Research and Manufacturing Services (CRAMS) over India and China.
She represented the industry in terms of capability of manufacturing of high tech dosage form of leading manufacturing companies likes Square, Incepta and Beximco.
Many of the pharma owners from Dubai, Turkey and Europe expressed their instant interest to do joint collaboration with Bangladesh pharma industries.
In the conference Dr Abdel Azim Dean of only one Pharma University of Kuwait was expressing his frustration for not expanding his research due to lack of resources.
Dr Zareen instantly committed to extend support to Kuwait Pharma R&D sector in all extent.
The moderator and organizing committee of congress remarked this was the biggest achievement of the conference.
Dr Zareen, professionally a cardiothoracic anesthesiologist, is an iconic first-generation female start up entrepreneur who initiated Invicta Health Care Limited for bringing world hit high technology pharma products and medical devices in Bangladesh at affordable price.